Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA-directed DNA polymerase, commonly known as reverse transcriptase (RT), is a key enzyme encoded by the human immunodeficiency virus (HIV). Its primary function is to catalyze the synthesis of complementary DNA (cDNA) from an RNA template, a process termed reverse transcription. This activity is essential for HIV replication and integration into the host genome. RT exhibits RNA-dependent DNA polymerase activity, DNA-dependent DNA polymerase activity, and Ribonuclease H activity. It is a major target for anti-HIV drug development.
Inhibition of reverse transcriptase activity, either through competitive inhibition (NRTIs) or allosteric inhibition (NNRTIs).
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA-directed DNA Polymerase (HIV) (RT).